KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $371.2 million.

  • Idexx Laboratories' Free Cash Flow rose 9335.69% to $371.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $963.6 million, marking a year-over-year increase of 2157.05%. This contributed to the annual value of $808.1 million for FY2024, which is 455.44% up from last year.
  • According to the latest figures from Q3 2025, Idexx Laboratories' Free Cash Flow is $371.2 million, which was up 9335.69% from $151.6 million recorded in Q2 2025.
  • Idexx Laboratories' 5-year Free Cash Flow high stood at $371.2 million for Q3 2025, and its period low was $35.8 million during Q2 2022.
  • In the last 5 years, Idexx Laboratories' Free Cash Flow had a median value of $172.8 million in 2023 and averaged $175.9 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first soared by 59339.36% in 2021, then crashed by 8308.02% in 2022.
  • Quarter analysis of 5 years shows Idexx Laboratories' Free Cash Flow stood at $178.2 million in 2021, then plummeted by 30.29% to $124.2 million in 2022, then skyrocketed by 74.96% to $217.3 million in 2023, then increased by 7.12% to $232.8 million in 2024, then soared by 59.48% to $371.2 million in 2025.
  • Its Free Cash Flow stands at $371.2 million for Q3 2025, versus $151.6 million for Q2 2025 and $207.9 million for Q1 2025.